SecBot SecBot
SECBOTREPLAY Home › Report › NVCR

NVCR · NovoCure announced that CMS rescinded the prior revocation of its…

NovoCure Ltd · 8-K filed Feb 24, 2026 at 17:00 ET

At the news

NEUTRALIMPACT 5/10

8-K filed Feb 24, 2026 at 17:00 ET

NovoCure announced that CMS rescinded the prior revocation of its Medicare billing privileges, reinstating them retroactively to December 17, 2025. The revocation was due to an administrative issue, not a substantive failure, and the company continued patient services during the period, expecting no revenue impact.

  • CMS revoked NovoCure's Medicare billing privileges retroactive to December 17, 2025, due to an administrative process issue with triannual re-validation.
  • On February 24, 2026, CMS rescinded the revocation and reinstated billing privileges retroactively to December 17, 2025.
  • The company continued providing services to existing and new patients during the period of ineligibility.
  • NovoCure believes there will be no impact on its ability to recognize revenue for services provided during the lapse.

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access